Law360: $200M MLB Antitrust Deal Cutting Cost of Web Streams OK’d

Law360: $200M MLB Antitrust Deal Cutting Cost of Web Streams OK’d

Law360’s Pete Brush reports on the $200M MLB Antitrust Deal Cutting Cost of Web Streams OK’d. Manhattan U.S. District Judge Shira A. Scheindlin gave final approval Monday for an antitrust class action deal worth $200 million that drops the price Major League Baseball junkies pay to watch online, awarding $16.5 million to plaintiffs’ counsel and turning aside an objector who said the settlement gives no relief for those who have stopped watching.

Law 360: MLB Fans Get Initial OK For TV Antitrust Settlement

Law 360: MLB Fans Get Initial OK For TV Antitrust Settlement

Law360’s Jeff Zelesin reports that MLB Fans Get Initial OK for TV Antitrust Settlement. Major League Baseball fans who were taking the league to trial over its business model for out-of-market game broadcasts won a New York federal judge’s initial approval Friday to settle the antitrust class action in exchange for some new viewing options and discounts.

Football Fans, Sports Bars File Antitrust Suit Challenging NFL Broadcasting Agreement

Football Fans, Sports Bars File Antitrust Suit Challenging NFL Broadcasting Agreement

The 32 teams in the National Football League (NFL) have unlawfully agreed to eliminate competition among themselves in broadcasting NFL games, according to a class action lawsuit filed in federal court. Represented by Cohen Milstein Sellers & Toll PLLC, bar owners and football fans from around the country seek an injunction to put an end to this anticompetitive arrangement and damages to compensate for the overcharges they have paid in purchasing access to live NFL broadcasts.

Law 360: Apotex’s Claim Of Provigil Monopoly To Be Decided At Trial

Law 360: Apotex’s Claim Of Provigil Monopoly To Be Decided At Trial

A Pennsylvania federal judge on Tuesday refused to grant Apotex Inc. summary judgment that Cephalon Inc. had monopoly power over the market for modafinil, the active ingredient in the narcolepsy drug Provigil, saying that disputed issues exist that should be resolved at trial. Vin Gurrieri reported for Law 360 in Apotex’s Claim Of Provigil Monopoly To Be Decided At Trial.